Search

You searched for "blurred"

619 results found

A case of ‘60-day glaucoma’

3 April 2023 | | EYE - General
Neovascular glaucoma (NVG) has been called ‘90-’ or ‘100-day glaucoma’ in the past due to its typical development three months after the onset of central retinal vein occlusion (CRVO). In reality, NVG can occur anywhere between two weeks and two...

The reps

1 August 2019 | | EYE - General
Who are the reps? Every one of us knows the friendly face of the local randomprost eye drop representative or the nice man from that eye lubricant company. These company representatives travel up and down the region with a smile,...

Visual disturbance heralding stroke: are we seeing the signs in time?

6 April 2021 | | EYE - Neuro-ophthalmology, EYE - General
Isolated visual symptoms may be an early presenting feature of stroke, and timely recognition of such atypical cases is important because treatment for stroke has a limited time-window of efficacy. Stroke occurs in approximately 150,000 people per year in the...

VisionSpring’s screening methodology is adopted by the World Health Organisation to increase global access to reading glasses

9 January 2023
By endorsing the training of health workers and nurses to identify blurry near vision and dispense reading glasses, the WHO’s new training program is helping solve this billion person issue.

Dramatic myopic shift due to epithelial basement membrane dystrophy

3 October 2024 | | EYE - Cornea
Epithelial basement membrane dystrophy (EBMD), also known as map-dot-fingerprint dystrophy, is a common anterior corneal disorder affecting approximately 2% of the population [1]. It is characterised by the abnormal maintenance of the basement membrane, resulting in protrusions into the epithelium....

Strange Sequelae Succeeding ‘Surfer’s Eye’

1 February 2014 |
Ophthalmologists in the UK are relatively infrequently faced with a patient requesting surgery for a pterygium. This condition is more common where ultraviolet exposure is greater, especially if coupled with activities associated with ocular surface irritation. For this reason, a...

Assessing everyday visual function in dry AMD – what matters to the person?

1 April 2019 | | EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the primary cause of blindness in the developed world and is accountable for more than one half of sight impairment registrations within England and Wales [1]. AMD is prevalent in people aged 60 years and...

Are we short-sighted about myopia?

1 December 2017 | | EYE - Cataract, EYE - Refractive, EYE - General
Worldwide prevalence of myopia has increased rapidly in recent years and has now reached epidemic levels, particularly in South-East Asia where prevalence is around 80% [1-4]. Myopia prevalence is also increasing in the United States and Europe where it is...

“I can see fine. Why do I need my eyes tested?”

2 December 2019 | | EYE - General
Are routine eye examinations really necessary? The author asks whether frequent appointments in low-risk patients with normal results are actually cost-effective. It’s recommended that most people should get their eyes tested every two years.” [1] This message is widely publicised...

We are all Hadiza

1 February 2018 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
When I worked as a registrar at Newport many years ago I remember a no-nonsense corneal consultant railing about the way the tragic case of Lucie Linforth was being reported in the media. Lucie was a toddler taken into a...

New genomic test saves Moorfields patient’s sight

6 May 2025 | news, patient stories, leptospirosis, diagnosis, rare, inflammation
Moorfields patient Ellie Irwin’s stubborn and debilitating eye inflammation was successfully treated as a result of a new metagenomic service identifying the cause of this as a rare infection. In 2019, Ellie first got symptoms of uveitis, a condition characterised...

Treatment for cause of sudden sight loss now available through the NHS in England

24 September 2025 | LHON, NICE, vision Loss, mitochondrial disease, NHS England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...